MAY 23·BenzingaMed
Inventiva reports 2025 First Quarter Financial Information¹ - Inventiva ( OTC:IVEVF ) , Inventiva ( NASDAQ:IVA )
Cash and cash equivalents at €67.9 million
Inventiva S.A.
No enriched coverage for $IVEVF in the last 7 days.
No SEC Form 4 filings for $IVEVF in the last 30 days.
Cash and cash equivalents at €67.9 million